SEC Form 4 · accession 0000899243-17-002205
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian Adams
Director
Period of report
Jan 25, 2017
Accepted (ET)
Jan 30, 2017 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.01 | Jan 25, 2017 | A | 20,000 | A | — | Jan 25, 2027 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017.